One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry study

BACKGROUND: Randomized clinical trials have demonstrated efficacy and safety of erenumab. The aim of this study is to evaluate the effectiveness and safety of erenumab in a real-world setting in French patients with migraine associated with extreme unmet needs. METHODS: This is a one year-prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanteri-Minet, M., Fabre, R., Martin, C., Pradat, K., Alchaar, A., Bozzolo, E., Duchene, M. L., Van Obberghen, E. K., Donnet, A., Fontaine, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633983/
https://www.ncbi.nlm.nih.gov/pubmed/37940860
http://dx.doi.org/10.1186/s10194-023-01680-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633983/
https://www.ncbi.nlm.nih.gov/pubmed/37940860
http://dx.doi.org/10.1186/s10194-023-01680-4

Ejemplares similares